WakeMed expands access to monoclonal antibody therapy
WakeMed is only the second provider in the state to join the national Crush COVID initiative, aimed at increasing access to this therapy for high-risk patients in underserved communities.
WakeMed is only the second provider in the state to join the national Crush COVID initiative, aimed at increasing access to this therapy for high-risk patients in underserved communities.